Tommy Thompson — February 2, 2016
“Senate should address Lyme and tick-borne disease epidemic”
He currently serves as an independent board member of US BIOLOGIC, which is developing a novel wildlife Lyme vaccine.
Krisztian Magori — September 8, 2015
“The Revenge of the Ticks!”
Fortunately, the tick’s saliva provides a number of such antigens, and these are currently used to develop such anti-tick vaccines. This strategy is also proposed by US Biologic to develop bait to control ticks in general.
Melinda Wenner Moyer — August 25, 2015
“The growing global battle against blood-sucking ticks”
Borrelia burgdorferi infects an estimated 329,000 people in the United States each year, according to the US Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia.
Leslie Mann — August 4, 2015
“Lyme disease still stuck in controversy, but there is hope”
“We want to kill Borrelia before it reaches humans,” said Mason Kauffman, CEO of Memphis-based US BIOLOGIC. In field trials, its rodent bait reduced Lyme-carrying ticks by 76 percent. After rodents eat the bait, their bodies create Lyme antibodies. When ticks bite these host rodents, the antibodies kill Borrelia in the tick.
“US BIOLOGIC targets mice with vaccine-coated snacks to prevent transmission of Lyme disease”
The threat of zoonotic diseases can turn the most avid outdoor enthusiast into a couch potato.
John Ferro — February 14, 2015
“Lyme: Are bacteria (or research) being starved to death?”
US Biologic, a Memphis-based company that does research on Lyme disease prevention, did a little extrapolation of a CDC study that estimated the total cost burden in 2002.
Jamie McGee — November 20, 2014
“Challenge Winner US Biologic Fights Lyme Disease”
The Cumberland Center, which seeks to invest in businesses and social enterprises making a difference in food and health, began its first investment last year with US Biologic, a company fighting Lyme disease.
“Stopping Disease in Its Tracks: A New Approach to Address Zoonotic Diseases”
In November 2013, US BIOLOGIC was recognized at the Global South Summit as the top company in the Global Food Health Innovation Challenge.
Katherine Barnett — October 2014
“The 2014 Innovation Awards: Dr. Maria Gomes-Selecki of UTHSC.”
September 3, 2014
“VaccineNation Names PaxVax CTO Dr. Thomas Monath #2 Most Influential Person in Vaccines”
“Tom is a pioneer in the development of vaccines against deadly diseases such as dengue and West Nile. His contributions have been invaluable as we’ve built out the industry’s most robust pipeline of specialty vaccine candidates for the compelling travel vaccine market.” — Kenneth Kelley, Chief Executive Officer of PaxVax.
Michael Waddel — June 11, 2014
“US Biologic preps new Lyme Disease vaccine for commercialization, new jobs”
US Biologic expects LymeShield, its groundbreaking vaccine to prevent the transmission of Lyme Disease, to have the necessary regulatory approvals and be ready for the commercial market sometime next year.
Melissa Pandika — April 17, 2014
“Fight Lyme Disease With a Vaccine – For Mice”
Since then, Gomes-Solecki has co-founded a company, U.S. Biologic, to market her vaccine, which is awaiting USDA approval. She expects it to hit the market in a few years.
Michael Sheffield — March 20, 2014
“U.S. Biologic moving forward with Lyme disease prevention product”
Memphis-based U.S. Biologic is looking to rabies prevention as inspiration for the launch of its first product.
Alyssa Botelho — March 5, 2014
“Mouse vaccine could protect humans from Lyme disease”
Our newest weapon against Lyme disease might be a vaccine – for mice.
Gabriel Miller — March 3, 2014
“Vaccine-laced mice bait lowers rate of Lyme disease bacteria in ticks”
Vaccinating mice can lower the proportion of ticks carrying the bacteria responsible for Lyme disease, according to a new study.
C.M. Rubin — February 25, 2014
“The Global Search For Education: Ticks – Breaking the Transmission Cycle of Lyme Disease”
What if we could vaccinate the white-footed mice that account for the majority of the transmission of Borrelia burgdorferi (the cause of Lyme disease) and significantly reduce the level of tick infection?
Bryan Cohen — February 14, 2014
“New technology may prevent Lyme disease transmission”
Researchers developed a new technology that may reduce the level of tick infection of Borrelia burgdorferi, the cause of Lyme disease, according to a study published on Wednesday in the Journal of Infectious Diseases.
Janis C. Kelly — February 14, 2014
“To Stop Lyme, Vaccinate…the mice?”
Maria Gomes-Solecki, DVM, and colleagues tested a new oral anti-OspA formulation that is being commercialized by US Biologic.
Monica Shelby — February 14, 2014
“Memphis Startup Proof Positive of the Power of Everywhere Else”
Earlier this week Memphis-based US Biologic announced the successful field trials of it’s revolutionary Lyme disease vaccine. The vaccine, given to animals orally, creates antibodies that then attack the Lyme disease passed on from a tick bite.
February 13, 2014
“Experimental Lyme Disease Vaccine Shown Effective”
The vaccine created by a company called U.S. Biologic was contained in pellets eaten by mice in a wooded area of New York over five years.
Maggie Fox — February 12, 2014
“Lyme Vaccine for Mice Could Protect People”
An experimental vaccine to control Lyme disease by targeting the mice that spread it cut the number of infected ticks by more than 75 percent after a couple of years, researchers reported Wednesday.
Bianca Phillips — December 5, 2013
“Ounce of Prevention”
Lyme disease sickens about 300,000 people per year, according to an August report from the Centers for Disease Control and Prevention, despite the fact that only 30,000 or so of those cases are reported annually.
But Memphis-based US Biologic and University of Tennessee Health Science Center professor Maria Gomes-Solecki are working on vaccination pellets for mice that would prevent the disease from spreading to humans.
December 2, 2013
Tennessee Representative Steve Cohen Recognizes US BIOLOGIC
Mr. Speaker, today I would like to recognize the work of Memphis-based U.S. Biologic in their work to halt the spread of Lyme disease. U.S. Biologic was recently awarded a grant of $1 million from the Global Food and Health Innovation Challenge to expand their research on this important topic and I am proud to honor the hard work of their dedicated research team, especially Maria Gomes-Solecki.
Staff — November 15, 2013
“Memphis company wins $1M innovation challenge”
Memphis-based company US Biologic won the $1 million Global Food and Health Innovation Challenge prize at the Global South Summit in Nashville this week for the development of a new product to prevent Lyme disease.
“A Hopeful Future for the Illusive Lyme Vaccine”
U.S. Biologic is currently pursuing USDA approval for their pellet vaccination, which if approved will be marketed to homeowners to sprinkle in hot-spot areas where ticks typically dwell.